Orgenesis Inc. (NASDAQ: ORGS) reported Q1 EPS of $0.17, $0.12 better than the analyst estimate of $0.05. Revenue for the quarter came in at $7.04 million versus the consensus estimate of $9.9 million.

For earnings history and earnings-related data on Orgenesis Inc. (ORGS) click here.